READDI, the Rapidly Emerging Antiviral Drug Development Initiative, has just received a big boost in accomplishing its mission of putting five antiviral drugs “on the shelf” ahead of future pandemics. The National Institutes of Health (NIH) announced Wednesday that READDI … Read more

In early 2020, the Eshelman Institute for Innovation helped launch the Rapidly Emerging Antiviral Drug Development Initiative (READDI). Since then, READDI has been collaborating with partners across the globe to bring broad-spectrum antiviral drugs through Phase 1 testing to be … Read more

In 2012, a revolutionary new way to edit genes was unveiled to the world – CRISPR. Since then, the technology has been named as a “Breakthrough of the Year” by Science and has expanded to be applied to targeted epigenome … Read more